Association of pelvic endometriosis with alopecia universalis, autoimmune thyroiditis and multiple sclerosis

Journal of Endocrinological Investigation

Volumn 29, Issue 2, 2006, Pages 182-189

  Alviggi, C ^a   Carrieri, P B ^a   Pivonello, R ^a   Scarano, V ^a   Pezzella, M ^a   De Placido, G ^a   Colao, A ^a   Matarese, G ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

Author keywords

Alopecia universalis; Autoimmune diseases; Autoimmune thyroiditis; Corticosteroids; HLA; Multiple sclerosis; Oestroprogestinic; Pelvic endometriosis

Indexed keywords

CORTICOSTEROID; ESTROGEN; GESTAGEN; HLA DR2 ANTIGEN; HLA DR3 ANTIGEN; PREDNISONE; THYROXINE;

ADULT; ALLELE; ALOPECIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTRAST RADIOGRAPHY; DISEASE ASSOCIATION; DRUG DOSE REGIMEN; DRUG MEGADOSE; DRUG WITHDRAWAL; ECHOGRAPHY; ENDOCRINE FUNCTION TEST; ENDOMETRIOSIS; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; HASHIMOTO DISEASE; HIGH RISK POPULATION; HLA TYPING; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; LAPAROSCOPIC SURGERY; LONG TERM CARE; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; RECURRENT DISEASE; RISK FACTOR; RISK MANAGEMENT; UROGENITAL TRACT RADIOGRAPHY; UTERUS SURGERY;

EID: 33645581225     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03344095     Document Type: Article

References (26)

1. Steinman L. Immune therapy for autoimmune diseases. Science, 2004, 305: 212-6.
2. Montanaro D, Sanna V, Matarese G, et al. The fine specificity of human T cell lines towards myelin basic protein peptides in southern Italian multiple sclerosis patients. Clin Exp Immunol 2001, 123: 288-93.
3. Sinaii N, Cleary SD, Ballweg ML, Nieman LK, Stratton P. High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis. Hum Reprod 2002, 17: 2715-24.
4. Nothnick WB. Treating endometriosis as an autoimmune disease. Fertil Steril 2001, 2: 223-31.
5. Matarese G, De Placido G, Nikas Y, Alviggi C. Pathogenesis of endometriosis: natural immunity dysfunction or autoimmune disease? Trends Mol Med 2003, 9: 223-8.
6. Valle RF, Sciarra JJ. Endometriosis: treatment strategies. Ann N Y Acad Sci 2003, 997: 229-39.
7. Nepom GT, Erlich H. MHC class-II molecules and autoimmunity. Annu Rev Immunol 1991, 9: 493-525.
8. Zetterquist H, Olerup O. Identification of the HLA-DRB1*04, -DRB1*07, and -DRB1*09 alleles by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Hum Immunol 1992, 34: 64-74.
9. The Americam Fertility Society. Revised American Fertility Society classification of endometriosis. Fertil Steril 1985, 3: 351-2.
10. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001, 1: 121-7.
11. Gallinelli A, Chiossi G, Giannella L, Marsella T, Genazzani AD, Volpe A. Different concentrations of interleukins in the peritoneal fluid of women with endometriosis: relationships with lymphocyte subsets. Gynecol Endocrinol 2004, 18: 144-151.
12. Ota H, Igarashi S. Expression of major histocompatibility complex class II antigen in endometriotic tissue in patients with endometriosis and adenomyosis. Fertil Steril 1993, 60: 834-8.
13. Gleicher N, el-Roeiy A, Confino E, Friberg J. Is endometriosis an autoimmune disease? Obstet Gynecol 1987, 70: 115-22.
14. Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocrine Rev 2002, 3: 327-64.
15. Pivonello R, De Bellis A, Faggiano A, et al. Central diabetes insipidus and autoimmunity: relationship between the occurrence of antibodies to arginine vasopressin-secreting cells and clinical, immunological, and radiological features in a large cohort of patients with central diabetes insipidus of known and unknown etiology. J Clin Endocrinol Metab 2003, 88: 1629-36.
16. Schloot N, Eisenbarth GR. Isohormonal therapy of endocrine autoimmunity. Immunol Today 1995, 16: 289-94.
17. Colao A, Pivonello R, Faggiano A, et al. Increased prevalence of thyroid autoimmunity in patients successfully treated for Cushing's disease. Clin Endocrinol (Oxf) 2000, 53: 13-9.
18. McGregor AM. Immunoendocrine interactions and autoimmunity. N Engl J Med 1990, 322: 1739-41.
19. Candrina R, Di Stefano O. Exacerbation of celiac disease after cure of Cushing's disease. Am J Med 1993, 95: 341.
20. Steuer A, Cavan DA, Lowy C. Sarcoidosis presenting after resection of an adrenocortical adenoma. BMJ 1995, 310: 56768.
21. Noguchi Y, Tamai H, Fujisawa K, et al. Systematic lupus erythematosus after pituitay adenomectomy in a patient with Cushing's disease. Clin Endocrinol (Oxf) 1998, 48: 670-2.
22. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol 2001, 2: 777-80.
23. Whitacre CC, Reingold SC, O'Looney PA. A gender gap in autoimmunity. Science 1999, 283: 1277-8.
24. Muller AF, Berghout A. Consequences of autoimmune thyroiditis before, during and after pregnancy. Minerva Endocrinol 2003, 28: 247-54.
25. Hernan MA, Hohol MJ, Olek MJ, Spiegelman D, Ascherio A. Oral contraceptives and the incidence of multiple sclerosis. Neurology 2000, 55: 848-54.
26. Thorogood M, Hannaford PC. The influence of oral contraceptives on the risk of multiple sclerosis. Br J Obstet Gynaecol 1998, 105: 1296-9.